GlassScriptPhysician profile
Violina Melnic
NPI 1982163978
$12,178.76
in general payments reported to CMS, 2019-2025
7 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $86.70 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $1,558 · Food and Beverage: $570 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $1,558.41 |
| Food and Beverage | $570.35 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,055.73 | 2025 | Activa PC, Percept PC Brainsense |
| Abbott Laboratories | $720.68 | 2025 | Infinity |
| Abbvie INC. | $161.38 | 2025 | |
| Boston Scientific Corporation | $154.27 | 2025 | Vercise, General - Dbs |
| Alexion Pharmaceuticals, INC. | $50.00 | 2024 | Ultomiris |
| Janssen Pharmaceuticals, INC | $18.50 | 2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $18.20 | 2024 | Farxiga |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Violina Melnic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.